The Traderszone Network

Published in TZ Latest News 6 September, 2017 by The TZ Newswire Staff

Sarepta Therapeutics Surges Following Duchenne Muscular Dystrophy Trial

Sarepta Therapeutics saw its shares make a handy gain on Wednesday after the firm announced muscle biopsy results from its mid-stage study for the treatment of Duchenne muscular dystrophy.